{"product_id":"tianeptine-sodium-125mg-90-capsulas-nootropics-depot","title":"Tianeptine Sodium 12.5mg · 90 Cápsulas · Nootropics Depot","description":"\u003cstyle\u003e\n.accordion .accordion__content,.accordion .accordion__content \u003e *,.product__description,.product__description \u003e *,.product__description .rte,.product__description .rte \u003e *,.rte \u003e .fnx-self,.rte .fnx-self{all:revert;background:transparent!important;color:inherit!important;max-width:none!important;width:100%!important;padding:0!important;margin:0!important;overflow:visible!important;display:block!important}\n.fnx-self{--blue:#1264ff;--blue2:#2d7cff;--cyan:#2be1ff;--dark:#020a1b;--dark2:#041936;--copy:#adc3de;--line:rgba(125,190,255,.16);all:initial!important;display:block!important;width:100%!important;max-width:none!important;margin:0!important;padding:0!important;color:#e8f4ff!important;font-family:Inter,-apple-system,BlinkMacSystemFont,'Segoe UI',sans-serif!important;font-size:15px!important;line-height:1.5!important;position:relative!important;box-sizing:border-box!important;overflow:visible!important;background:transparent!important}\n.fnx-self *,.fnx-self *::before,.fnx-self *::after{box-sizing:border-box!important}\n.fnx-self h2,.fnx-self h3{margin-top:0!important}\n.fnx-self p{color:var(--copy)!important;line-height:1.65!important;margin-top:0!important}\n.fnx-self .kicker{display:block!important;margin:0 0 12px!important;color:#2be1ff!important;font-size:10px!important;font-weight:800!important;letter-spacing:.2em!important;text-transform:uppercase!important}\n.fnx-presentation{position:relative!important;overflow:hidden!important;display:grid!important;grid-template-columns:.85fr 1.15fr!important;gap:clamp(30px,5vw,70px)!important;align-items:end!important;padding:clamp(34px,5vw,62px)!important;margin-bottom:28px!important;border:1px solid rgba(0,150,255,.2)!important;border-radius:28px!important;background:radial-gradient(42rem 27rem at 15% 20%,rgba(18,100,255,.16),transparent 66%),radial-gradient(35rem 25rem at 100% 90%,rgba(0,80,220,.22),transparent 68%),linear-gradient(135deg,rgba(4,20,60,.92),rgba(2,10,27,.97))!important;box-shadow:0 28px 80px rgba(2,10,27,.5),inset 0 1px rgba(255,255,255,.06)!important}\n.fnx-presentation::before{content:'';position:absolute;width:55%;height:220%;left:-35%;top:-70%;transform:rotate(17deg);background:linear-gradient(90deg,transparent,rgba(255,255,255,.04),transparent);animation:fnxGlass 9s ease-in-out infinite;pointer-events:none}\n@keyframes fnxGlass{0%,60%{left:-45%;opacity:0}70%{opacity:.7}100%{left:120%;opacity:0}}\n.fnx-presentation-copy{position:relative!important;z-index:2!important;display:block!important}\n.fnx-presentation h2{max-width:11ch!important;margin:0 0 18px!important;color:#fff!important;font-size:clamp(36px,4.5vw,61px)!important;line-height:.98!important;letter-spacing:-.055em!important;font-weight:780!important;display:block!important}\n.fnx-presentation-copy\u003ep:last-child{max-width:39ch!important;margin-bottom:0!important;font-size:15px!important}\n.fnx-facts{display:grid!important;grid-template-columns:repeat(2,minmax(0,1fr))!important;margin:0!important;padding:0!important;list-style:none!important}\n.fnx-fact{display:block!important;min-height:106px!important;padding:20px 22px 20px 0!important;border-top:1px solid rgba(0,150,255,.15)!important;background:transparent!important;margin:0!important}\n.fnx-fact:nth-child(even){padding-left:28px!important;border-left:1px solid rgba(0,150,255,.1)!important}\n.fnx-fact-label{display:block!important;margin:0 0 9px!important;color:#2be1ff!important;font-size:9px!important;font-weight:800!important;letter-spacing:.16em!important;text-transform:uppercase!important}\n.fnx-fact-value{display:block!important;color:#fff!important;font-size:15px!important;font-weight:700!important;margin:0!important}\n.fnx-stock{display:flex!important;align-items:center!important;gap:9px!important}\n.fnx-stock::before{content:''!important;width:7px!important;height:7px!important;flex:0 0 auto!important;border-radius:50%!important;background:#63ff93!important;box-shadow:0 0 8px #63ff93,0 0 20px rgba(99,255,147,.55)!important}\n.fnx-quick{position:relative!important;overflow:hidden!important;display:block!important;margin:0 0 28px!important;padding:clamp(36px,5vw,58px)!important;border-top:1px solid rgba(0,150,255,.2)!important;border-bottom:1px solid rgba(0,150,255,.14)!important;background:radial-gradient(38rem 22rem at 85% 20%,rgba(18,100,255,.14),transparent 66%),linear-gradient(120deg,rgba(4,20,60,.5),rgba(2,10,27,.75))!important}\n.fnx-quick::after{content:'';position:absolute;width:43%;aspect-ratio:1;right:-10%;bottom:-78%;border-radius:50%;background:radial-gradient(circle,rgba(43,225,255,.1),transparent 67%);filter:blur(12px);animation:fnxBreath 7s ease-in-out infinite}\n@keyframes fnxBreath{50%{transform:scale(1.12);opacity:.65}}\n.fnx-quick-head{position:relative!important;z-index:2!important;display:grid!important;grid-template-columns:.95fr .65fr!important;gap:35px!important;align-items:end!important;margin-bottom:30px!important}\n.fnx-quick h2{max-width:12ch!important;margin:0!important;color:#fff!important;font-size:clamp(34px,4vw,52px)!important;line-height:.98!important;letter-spacing:-.05em!important;display:block!important}\n.fnx-quick-head\u003ep{margin-bottom:0!important;max-width:46ch!important;font-size:14px!important}\n.fnx-quick-grid{position:relative!important;z-index:2!important;display:grid!important;grid-template-columns:repeat(4,minmax(0,1fr))!important;border-top:1px solid rgba(0,150,255,.15)!important}\n.fnx-key{position:relative!important;display:block!important;min-height:188px!important;padding:25px 24px 22px 0!important;background:transparent!important;transition:transform .35s ease,background .35s ease}\n.fnx-key+.fnx-key{padding-left:24px!important;border-left:1px solid rgba(0,150,255,.1)!important}\n.fnx-key:hover{transform:translateY(-6px)!important;background:radial-gradient(16rem 10rem at 50% 0,rgba(43,225,255,.06),transparent 70%)!important}\n.fnx-number{display:inline-grid!important;place-items:center!important;width:32px!important;height:32px!important;margin-bottom:23px!important;border:1px solid rgba(43,225,255,.3)!important;border-radius:50%!important;color:#2be1ff!important;font-size:9px!important;font-weight:800!important;line-height:1!important;padding:0!important;background:transparent!important;vertical-align:top!important;box-shadow:0 0 22px rgba(18,100,255,.1)!important}\n.fnx-key h3{display:block!important;margin:0 0 9px!important;color:#fff!important;font-size:17px!important;font-weight:700!important}\n.fnx-key p{display:block!important;margin:0!important;font-size:13px!important}\n.fnx-deep{position:relative!important;overflow:hidden!important;display:block!important;margin:0!important;border:1px solid rgba(0,150,255,.18)!important;border-radius:27px!important;background:linear-gradient(145deg,rgba(4,25,70,.93),rgba(2,10,27,.98))!important;box-shadow:0 32px 85px rgba(2,10,27,.5),inset 0 1px rgba(255,255,255,.05)!important}\n.fnx-deep\u003esummary{position:relative!important;display:grid!important;grid-template-columns:42px 1fr auto!important;gap:16px!important;align-items:center!important;min-height:96px!important;padding:20px 28px!important;color:#fff!important;cursor:pointer!important;list-style:none!important;background:radial-gradient(34rem 15rem at 10% 0,rgba(43,225,255,.08),transparent 65%)!important}\n.fnx-deep\u003esummary::-webkit-details-marker{display:none!important}\n.fnx-signal{position:relative!important;display:inline-block!important;width:38px!important;height:38px!important;border:1px solid rgba(43,225,255,.4)!important;border-radius:50%!important;background:radial-gradient(circle,#2be1ff 0 2px,transparent 3px)!important;box-shadow:0 0 18px rgba(18,100,255,.14)!important;flex-shrink:0!important}\n.fnx-signal::after{content:'';position:absolute;inset:8px;border:1px solid rgba(43,225,255,.16);border-radius:50%;animation:fnxSignal 2.7s ease-in-out infinite}\n@keyframes fnxSignal{50%{transform:scale(1.32);opacity:.2}}\n.fnx-deep-label{display:grid!important;gap:3px!important}\n.fnx-deep-label strong{display:block!important;font-size:18px!important;letter-spacing:.02em!important;color:#fff!important;font-weight:700!important}\n.fnx-deep-label small{display:block!important;color:#5a8aaa!important;font-size:12px!important}\n.fnx-arrow{display:inline-grid!important;place-items:center!important;width:37px!important;height:37px!important;border:1px solid rgba(43,225,255,.28)!important;border-radius:50%!important;color:#2be1ff!important;background:transparent!important;transition:transform .4s ease;font-size:16px!important}\n.fnx-deep[open] .fnx-arrow{transform:rotate(180deg)!important}\n.fnx-deep-content{display:block!important;animation:fnxOpen .45s ease}\n@keyframes fnxOpen{from{opacity:0;transform:translateY(15px)}}\n.fnx-history{display:grid!important;grid-template-columns:.72fr 1.28fr!important;gap:clamp(38px,6vw,84px)!important;padding:clamp(56px,7vw,92px)!important;border-top:1px solid rgba(0,150,255,.1)!important;background:radial-gradient(40rem 24rem at 15% 25%,rgba(18,100,255,.1),transparent 70%),linear-gradient(145deg,rgba(4,20,60,.98),rgba(2,14,40,.82))!important}\n.fnx-history h2{max-width:8ch!important;margin:0 0 22px!important;color:#fff!important;font-size:clamp(48px,6vw,77px)!important;line-height:.94!important;letter-spacing:-.06em!important;font-weight:780!important;display:block!important}\n.fnx-history-intro\u003ep:last-child{max-width:29ch!important;margin-bottom:0!important}\n.fnx-timeline{position:relative!important;margin:0!important;padding:0 0 0 43px!important;list-style:none!important}\n.fnx-timeline::before{content:'';position:absolute;left:8px;top:7px;bottom:8px;width:1px;background:linear-gradient(180deg,#2be1ff,#1264ff 30%,#0040cc 72%,transparent);box-shadow:0 0 12px rgba(43,225,255,.5),0 0 28px rgba(18,100,255,.25)}\n.fnx-timeline li{position:relative!important;display:block!important;padding:0 0 43px!important;opacity:.72!important;background:transparent!important;transition:transform .35s ease,opacity .35s ease}\n.fnx-timeline li:last-child{padding-bottom:0!important}\n.fnx-timeline li:hover{opacity:1!important;transform:translateX(6px)!important}\n.fnx-node{position:absolute!important;left:-42px!important;top:4px!important;width:17px!important;height:17px!important;border:1px solid #2be1ff!important;border-radius:50%!important;background:#020a1b!important;box-shadow:0 0 0 4px rgba(43,225,255,.05),0 0 12px rgba(43,225,255,.15)!important;transition:background .35s ease,box-shadow .35s ease!important}\n.fnx-timeline li:hover .fnx-node{background:#2be1ff!important;box-shadow:0 0 0 6px rgba(43,225,255,.08),0 0 18px #2be1ff,0 0 34px rgba(18,100,255,.5)!important}\n.fnx-date{display:block!important;margin:0 0 7px!important;color:#2be1ff!important;font-size:9px!important;font-weight:800!important;letter-spacing:.18em!important;text-transform:uppercase!important}\n.fnx-timeline h3{display:block!important;margin:0 0 8px!important;color:#fff!important;font-size:20px!important;font-weight:700!important}\n.fnx-timeline p:last-child{margin-bottom:0!important;font-size:14px!important}\n.fnx-science{display:grid!important;grid-template-columns:1.1fr .9fr!important;gap:clamp(40px,6vw,84px)!important;align-items:center!important;padding:clamp(62px,8vw,106px)!important;border-top:1px solid rgba(0,150,255,.1)!important;background:radial-gradient(48rem 32rem at 22% 50%,rgba(18,100,255,.1),transparent 67%),radial-gradient(48rem 32rem at 90% 15%,rgba(0,60,180,.18),transparent 67%),linear-gradient(130deg,#041430,#020a1b 72%)!important}\n.fnx-molecule{position:relative!important;min-height:480px!important;display:grid!important;place-items:center!important;perspective:1200px!important}\n.fnx-molecule::before{content:'';position:absolute;inset:5%;z-index:0;border-radius:50%;background:radial-gradient(circle,rgba(43,225,255,.28) 0%,rgba(18,100,255,.15) 30%,rgba(0,60,180,.06) 60%,transparent 75%);filter:blur(18px);animation:fnxMolAura 5.5s ease-in-out infinite;pointer-events:none;transition:opacity .5s ease}\n.fnx-molecule:hover::before{filter:blur(22px)!important}\n@keyframes fnxMolAura{0%,100%{opacity:.55;transform:scale(1)}50%{opacity:1;transform:scale(1.12)}}\n.fnx-molecule-stage{position:relative!important;z-index:2!important;width:100%!important;max-width:560px!important;min-height:390px!important;display:grid!important;place-items:center!important;transform-style:preserve-3d!important;transition:transform .55s cubic-bezier(.16,1,.3,1)!important}\n.fnx-molecule:hover .fnx-molecule-stage{transform:rotateX(-5deg) rotateY(10deg) translateY(-8px) scale(1.04)!important}\n.fnx-molecule-svg{position:relative!important;z-index:3!important;width:108%!important;max-width:580px!important;height:auto!important;display:block!important;filter:drop-shadow(0 0 12px rgba(43,225,255,.8)) drop-shadow(0 0 32px rgba(18,100,255,.55)) drop-shadow(0 0 56px rgba(0,60,180,.3))!important;animation:fnxMolFloat 6.5s ease-in-out infinite!important;transition:filter .55s ease!important}\n.fnx-molecule:hover .fnx-molecule-svg{filter:drop-shadow(0 0 22px rgba(43,225,255,1)) drop-shadow(0 0 55px rgba(18,100,255,.9)) drop-shadow(0 0 90px rgba(0,60,180,.6))!important}\n@keyframes fnxMolFloat{0%,100%{transform:translateY(0) scale(1)}50%{transform:translateY(-10px) scale(1.014)}}\n.fnx-orbit{position:absolute!important;left:50%!important;top:49%!important;width:90%!important;height:42%!important;border:1px solid rgba(43,225,255,.25)!important;border-radius:50%!important;pointer-events:none!important;z-index:1!important}\n.fnx-orbit-a{transform:translate(-50%,-50%) rotate(-10deg)!important;animation:fnxOrbitA 14s linear infinite!important}\n.fnx-orbit-b{width:72%!important;height:58%!important;border-color:rgba(18,100,255,.2)!important;transform:translate(-50%,-50%) rotate(55deg)!important;animation:fnxOrbitB 18s linear infinite!important}\n@keyframes fnxOrbitA{to{transform:translate(-50%,-50%) rotate(350deg)}}\n@keyframes fnxOrbitB{to{transform:translate(-50%,-50%) rotate(415deg)}}\n.fnx-platform{position:absolute!important;left:10%!important;right:10%!important;bottom:4%!important;height:18%!important;z-index:1!important;border-radius:50%!important;background:radial-gradient(ellipse at 50% 40%,rgba(43,225,255,.3),rgba(18,100,255,.18) 18%,rgba(0,60,180,.08) 42%,transparent 70%)!important}\n.fnx-platform::before{content:'';position:absolute;inset:28% 8%;border:1px solid rgba(43,225,255,.45);border-radius:50%;box-shadow:0 0 28px rgba(43,225,255,.2),0 0 50px rgba(18,100,255,.1);animation:fnxPlatform 3s ease-in-out infinite}\n@keyframes fnxPlatform{0%,100%{opacity:.7;transform:scale(1)}50%{opacity:1;transform:scale(1.1)}}\n.fnx-molecule-meta{position:absolute!important;left:1%!important;bottom:1%!important;z-index:6!important;padding:12px 15px!important;border-left:2px solid rgba(43,225,255,.5)!important;background:linear-gradient(90deg,rgba(2,10,27,.85),transparent)!important}\n.fnx-molecule-meta strong{display:block!important;color:#e0f8ff!important;font-size:11px!important;letter-spacing:.1em!important}\n.fnx-molecule-meta span{display:block!important;margin-top:5px!important;color:#5a8aaa!important;font-size:9px!important;line-height:1.5!important}\n.fnx-science-copy h2{max-width:11ch!important;margin:0 0 20px!important;color:#fff!important;font-size:clamp(42px,5vw,67px)!important;line-height:.96!important;letter-spacing:-.055em!important;display:block!important}\n.fnx-science-lead{margin-bottom:32px!important;font-size:15px!important}\n.fnx-topics{display:grid!important}\n.fnx-topic{display:grid!important;grid-template-columns:38px 1fr!important;gap:14px!important;padding:18px 0!important;border-top:1px solid rgba(0,150,255,.15)!important;transition:transform .3s ease!important}\n.fnx-topic:hover{transform:translateX(7px)!important}\n.fnx-topic\u003espan{display:block!important;color:#2be1ff!important;font-size:10px!important;font-weight:800!important}\n.fnx-topic h3{display:block!important;margin:0 0 5px!important;color:#fff!important;font-size:16px!important;font-weight:700!important}\n.fnx-topic p{display:block!important;margin:0!important;font-size:13px!important}\n.fnx-benefits{display:grid!important;grid-template-columns:1fr 1fr!important;gap:clamp(30px,5vw,60px)!important;padding:clamp(58px,7vw,92px)!important;border-top:1px solid rgba(0,150,255,.1)!important;background:radial-gradient(40rem 24rem at 90% 20%,rgba(18,100,255,.1),transparent 70%),linear-gradient(145deg,rgba(4,20,55,.98),rgba(2,10,27,.82))!important}\n.fnx-benefits-intro h2{max-width:10ch!important;margin:0 0 18px!important;color:#fff!important;font-size:clamp(38px,4.5vw,58px)!important;line-height:.98!important;letter-spacing:-.05em!important;display:block!important}\n.fnx-benefits-intro p{font-size:14px!important;margin-bottom:0!important}\n.fnx-benefits-grid{display:grid!important;gap:0!important}\n.fnx-benefit{display:grid!important;grid-template-columns:38px 1fr!important;gap:14px!important;padding:18px 0!important;border-top:1px solid rgba(0,150,255,.15)!important;background:transparent!important;transition:transform .3s ease}\n.fnx-benefit:hover{transform:translateX(7px)!important}\n.fnx-benefit-num{display:block!important;color:#2be1ff!important;font-size:10px!important;font-weight:800!important;padding-top:2px!important;line-height:1.4!important}\n.fnx-benefit h3{display:block!important;margin:0 0 5px!important;color:#fff!important;font-size:16px!important;font-weight:700!important}\n.fnx-benefit p{display:block!important;margin:0!important;font-size:13px!important}\n.fnx-audience{display:grid!important;grid-template-columns:.62fr 1.38fr!important;gap:clamp(38px,6vw,84px)!important;padding:clamp(58px,7vw,92px)!important;border-top:1px solid rgba(0,150,255,.1)!important;background:radial-gradient(40rem 24rem at 100% 10%,rgba(18,100,255,.12),transparent 70%),linear-gradient(150deg,rgba(4,20,55,.92),rgba(2,10,27,.98))!important}\n.fnx-audience h2{max-width:9ch!important;margin:0!important;color:#fff!important;font-size:clamp(42px,5vw,64px)!important;line-height:.96!important;letter-spacing:-.055em!important;display:block!important}\n.fnx-audience-grid{display:grid!important;gap:0!important}\n.fnx-audience-item{display:block!important;padding:20px 0!important;border-top:1px solid rgba(0,150,255,.15)!important;background:transparent!important}\n.fnx-audience-item h3{display:block!important;margin:0 0 7px!important;color:#fff!important;font-size:17px!important;font-weight:700!important}\n.fnx-audience-item p{display:block!important;margin:0!important;font-size:13.5px!important}\n.fnx-questions{display:grid!important;grid-template-columns:.62fr 1.38fr!important;gap:clamp(38px,6vw,84px)!important;padding:clamp(58px,7vw,92px)!important;border-top:1px solid rgba(0,150,255,.1)!important;background:radial-gradient(40rem 24rem at 0% 50%,rgba(18,100,255,.08),transparent 70%),linear-gradient(150deg,rgba(2,15,45,.92),rgba(2,10,27,.98))!important}\n.fnx-questions h2{max-width:9ch!important;margin:0!important;color:#fff!important;font-size:clamp(42px,5vw,64px)!important;line-height:.96!important;letter-spacing:-.055em!important;display:block!important}\n.fnx-question{display:block!important;padding:20px 0!important;border-top:1px solid rgba(0,150,255,.15)!important;background:transparent!important}\n.fnx-question h3{display:block!important;margin:0 0 7px!important;color:#fff!important;font-size:17px!important;font-weight:700!important}\n.fnx-question p{display:block!important;margin:0!important;font-size:13.5px!important}\n.fnx-close{position:relative!important;overflow:hidden!important;display:grid!important;grid-template-columns:1.25fr .75fr!important;gap:clamp(30px,5vw,65px)!important;align-items:center!important;margin:0!important;padding:clamp(38px,5vw,62px)!important;border-top:1px solid rgba(0,150,255,.22)!important;background:radial-gradient(34rem 22rem at 5% 0,rgba(18,100,255,.12),transparent 68%),radial-gradient(30rem 24rem at 105% 50%,rgba(0,60,180,.2),transparent 67%),linear-gradient(145deg,#041430,#020a1b)!important}\n.fnx-close::after{content:'';position:absolute;right:-12%;top:-75%;width:55%;aspect-ratio:1;border:1px solid rgba(43,225,255,.14);border-radius:50%;box-shadow:0 0 35px rgba(43,225,255,.05)}\n.fnx-close-copy,.fnx-actions{position:relative!important;z-index:2!important;display:block!important}\n.fnx-close h2{max-width:17ch!important;margin:8px 0 15px!important;color:#fff!important;font-size:clamp(31px,4vw,52px)!important;line-height:1.02!important;letter-spacing:-.045em!important;font-weight:780!important;display:block!important}\n.fnx-close-copy\u003ep:last-child{max-width:62ch!important;margin-bottom:0!important;font-size:14px!important}\n.fnx-actions{display:grid!important;gap:14px!important}\n.fnx-self a.fnx-btn{display:block!important;width:100%!important;padding:18px 28px!important;border-radius:10px!important;font-family:inherit!important;font-size:13px!important;font-weight:700!important;letter-spacing:.08em!important;line-height:1.2!important;text-align:center!important;text-decoration:none!important;text-transform:uppercase!important;cursor:pointer!important;transition:transform .28s ease,box-shadow .28s ease,background .28s ease!important}\n.fnx-self a.fnx-btn-primary{color:#e8f4ff!important;background:rgba(4,40,120,.8)!important;border:1px solid rgba(43,225,255,.55)!important;box-shadow:0 0 20px rgba(18,100,255,.22)!important}\n.fnx-self a.fnx-btn-primary:hover{background:rgba(10,60,180,.9)!important;transform:translateY(-3px)!important}\n.fnx-self a.fnx-btn-secondary{color:rgba(150,210,255,.75)!important;background:transparent!important;border:1px solid rgba(43,225,255,.25)!important}\n.fnx-self a.fnx-btn-secondary:hover{color:#2be1ff!important;border-color:rgba(43,225,255,.42)!important;background:rgba(18,100,255,.07)!important;transform:translateY(-3px)!important}\n@media(max-width:900px){.fnx-presentation,.fnx-quick-head,.fnx-history,.fnx-science,.fnx-benefits,.fnx-audience,.fnx-questions,.fnx-close{grid-template-columns:1fr!important}.fnx-quick-grid{grid-template-columns:repeat(2,minmax(0,1fr))!important}.fnx-molecule{min-height:380px!important}}\n@media(max-width:620px){.fnx-presentation{padding:34px 21px!important;border-radius:22px!important}.fnx-facts{grid-template-columns:1fr!important}.fnx-fact,.fnx-fact:nth-child(even){min-height:0!important;padding:16px 0!important;border-left:0!important}.fnx-quick{padding:38px 20px!important}.fnx-quick-grid{grid-template-columns:1fr!important}.fnx-key,.fnx-key+.fnx-key{min-height:0!important;padding:21px 0!important;border-left:0!important;border-top:1px solid rgba(0,150,255,.15)!important}.fnx-deep{border-radius:22px!important}.fnx-deep\u003esummary{grid-template-columns:35px 1fr auto!important;gap:11px!important;padding:18px 15px!important}.fnx-history,.fnx-science,.fnx-benefits,.fnx-audience,.fnx-questions,.fnx-close{padding:47px 20px!important}.fnx-molecule{min-height:300px!important}.fnx-molecule-svg{width:115%!important}.fnx-close{grid-template-columns:1fr!important}}\n@media(prefers-reduced-motion:reduce){.fnx-self *,.fnx-self *::before,.fnx-self *::after{animation:none!important;transition:none!important}}\n\u003c\/style\u003e\n\u003cdiv class=\"fnx-self\"\u003e\n\u003csection class=\"fnx-presentation\"\u003e\n\u003cdiv class=\"fnx-presentation-copy\"\u003e\n\u003cp class=\"kicker\"\u003eESTA PRESENTACIÓN · RESEARCH USE ONLY\u003c\/p\u003e\n\u003ch2\u003eModulador de recaptación de serotonina.\u003c\/h2\u003e\n\u003cp\u003eTianeptine Sodium · 12.5 mg · 90 cápsulas · Nootropics Depot. Sal sódica de alta biodisponibilidad para investigación sobre regulación serotoninérgica.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-facts\"\u003e\n\u003cdiv class=\"fnx-fact\"\u003e\n\u003cp class=\"fnx-fact-label\"\u003eMarca\u003c\/p\u003e\n\u003cp class=\"fnx-fact-value\"\u003eNootropics Depot\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-fact\"\u003e\n\u003cp class=\"fnx-fact-label\"\u003ePresentación\u003c\/p\u003e\n\u003cp class=\"fnx-fact-value\"\u003e90 cápsulas · 12.5 mg c\/u\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-fact\"\u003e\n\u003cp class=\"fnx-fact-label\"\u003eContenido declarado\u003c\/p\u003e\n\u003cp class=\"fnx-fact-value\"\u003e1,125 mg totales · CAS 30123-17-2\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-fact\"\u003e\n\u003cp class=\"fnx-fact-label\"\u003eDisponibilidad\u003c\/p\u003e\n\u003cp class=\"fnx-fact-value fnx-stock\"\u003eEn existencia · RUO\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"fnx-quick\"\u003e\n\u003cdiv class=\"fnx-quick-head\"\u003e\n\u003cdiv\u003e\n\u003cp class=\"kicker\"\u003eLO ESENCIAL EN SEGUNDOS\u003c\/p\u003e\n\u003ch2\u003eTianeptina Sodio, en cuatro claves.\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cp\u003eLo que necesitas saber antes de decidir: mecanismo, presentación, sal sódica vs. sulfato, y perfil de investigación documentado.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-quick-grid\"\u003e\n\u003carticle class=\"fnx-key\"\u003e\u003cspan class=\"fnx-number\"\u003e01\u003c\/span\u003e\u003ch3\u003eSERT atípico\u003c\/h3\u003e\n\u003cp\u003eA diferencia de los ISRS, la tianeptina potencia la recaptación de serotonina en lugar de inhibirla. Mecanismo único en su clase con efectos documentados sobre plasticidad sináptica.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-key\"\u003e\u003cspan class=\"fnx-number\"\u003e02\u003c\/span\u003e\u003ch3\u003eAgonismo μ-opioide\u003c\/h3\u003e\n\u003cp\u003eActividad agonista sobre receptores μ y δ-opioides a dosis elevadas — relevante para investigación sobre analgesia, estado de ánimo y neuroadaptación.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-key\"\u003e\u003cspan class=\"fnx-number\"\u003e03\u003c\/span\u003e\u003ch3\u003e12.5 mg · 90 caps\u003c\/h3\u003e\n\u003cp\u003e1,125 mg totales. Sal sódica de inicio de acción rápido (~30 min). Dosificación estándar de investigación: 12.5 mg 2–3 veces\/día con intervalos regulares.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-key\"\u003e\u003cspan class=\"fnx-number\"\u003e04\u003c\/span\u003e\u003ch3\u003eSal sódica vs. sulfato\u003c\/h3\u003e\n\u003cp\u003eLa forma sódica presenta mayor solubilidad acuosa y biodisponibilidad oral frente al sulfato. Inicio más rápido, duración más corta — perfil distinto para protocolos comparativos.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdetails class=\"fnx-deep\" open\u003e\n\u003csummary\u003e\u003cspan class=\"fnx-signal\"\u003e\u003c\/span\u003e\u003cspan class=\"fnx-deep-label\"\u003e\u003cstrong\u003ePROFUNDIZA\u003c\/strong\u003e\u003csmall\u003eHistoria · molécula · mecanismo · identidad química · preguntas clave\u003c\/small\u003e\u003c\/span\u003e\u003cspan class=\"fnx-arrow\"\u003e↓\u003c\/span\u003e\u003c\/summary\u003e\n\u003cdiv class=\"fnx-deep-content\"\u003e\n\u003csection class=\"fnx-history\"\u003e\n\u003cheader class=\"fnx-history-intro\"\u003e\n\u003cp class=\"kicker\"\u003eHISTORIA Y CONTEXTO\u003c\/p\u003e\n\u003ch2\u003eDel laboratorio francés al RUO global.\u003c\/h2\u003e\n\u003cp\u003eLa tianeptina tiene una historia clínica de más de cuatro décadas que precede su migración al ámbito de investigación no supervisada.\u003c\/p\u003e\n\u003c\/header\u003e\n\u003col class=\"fnx-timeline\"\u003e\n\u003cli\u003e\n\u003cspan class=\"fnx-node\"\u003e\u003c\/span\u003e\u003cp class=\"fnx-date\"\u003e1960s\u003c\/p\u003e\n\u003ch3\u003eSíntesis por IPSEN \/ Servier\u003c\/h3\u003e\n\u003cp\u003eDesarrollada en Francia por los Laboratoires Servier. Aprobada en Europa y América Latina como antidepresivo bajo el nombre comercial Stablon®. Nunca aprobada por la FDA para uso médico en EE.UU.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"fnx-node\"\u003e\u003c\/span\u003e\u003cp class=\"fnx-date\"\u003e1980s – 2000s\u003c\/p\u003e\n\u003ch3\u003eInvestigación clínica europea\u003c\/h3\u003e\n\u003cp\u003eAmplia literatura clínica sobre depresión, ansiedad y síndrome de intestino irritable. Descubrimiento del mecanismo opioide como componente secundario de su actividad farmacológica.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"fnx-node\"\u003e\u003c\/span\u003e\u003cp class=\"fnx-date\"\u003e2010s\u003c\/p\u003e\n\u003ch3\u003eRestricciones regulatorias\u003c\/h3\u003e\n\u003cp\u003eMúltiples países restringen o retiran la tianeptina de suplementos tras reportes de dependencia y abuso. La FDA emite alertas en 2022. Migra al ámbito RUO en mercados no regulados para uso clínico.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"fnx-node\"\u003e\u003c\/span\u003e\u003cp class=\"fnx-date\"\u003eActualidad\u003c\/p\u003e\n\u003ch3\u003eMaterial de referencia Nootropics Depot\u003c\/h3\u003e\n\u003cp\u003eNootropics Depot formula Tianeptine Sodium como cápsulas de 12.5 mg de alta pureza para investigación sobre regulación serotoninérgica, neuroplasticidad y farmacología opioide comparativa.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003csection class=\"fnx-science\"\u003e\n\u003cdiv class=\"fnx-molecule\"\u003e\n\u003cdiv class=\"fnx-orbit fnx-orbit-a\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"fnx-orbit fnx-orbit-b\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"fnx-molecule-stage\"\u003e\n\u003csvg class=\"fnx-molecule-svg\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"620\" height=\"360\" role=\"img\" aria-label=\"Estructura molecular de Tianeptina Sódica\"\u003e\n\u003cdefs\u003e\n\u003cfilter id=\"fnxMolGlowB\" x=\"-50%\" y=\"-50%\" width=\"200%\" height=\"200%\"\u003e\n\u003cfegaussianblur stddeviation=\"4\" result=\"b\"\u003e\u003c\/fegaussianblur\u003e\n\u003cfemerge\u003e\u003cfemergenode in=\"b\"\u003e\u003c\/femergenode\u003e\u003cfemergenode in=\"b\"\u003e\u003c\/femergenode\u003e\u003cfemergenode in=\"SourceGraphic\"\u003e\u003c\/femergenode\u003e\u003c\/femerge\u003e\n\u003c\/filter\u003e\n\u003c\/defs\u003e\n\u003cg fill=\"none\" stroke=\"#5BC8FF\" stroke-width=\"3.2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" filter=\"url(#fnxMolGlowB)\"\u003e\n\u003c!-- Núcleo tricíclico --\u003e\n\u003cpolygon points=\"120,200 155,155 210,155 245,200 210,245 155,245\"\u003e\u003c\/polygon\u003e\n\u003cline x1=\"245\" y1=\"200\" x2=\"310\" y2=\"200\"\u003e\u003c\/line\u003e\n\u003c!-- Cadena lateral --\u003e\n\u003cline x1=\"310\" y1=\"200\" x2=\"345\" y2=\"155\"\u003e\u003c\/line\u003e\n\u003cline x1=\"345\" y1=\"155\" x2=\"415\" y2=\"155\"\u003e\u003c\/line\u003e\n\u003cline x1=\"415\" y1=\"155\" x2=\"450\" y2=\"200\"\u003e\u003c\/line\u003e\n\u003cline x1=\"450\" y1=\"200\" x2=\"520\" y2=\"200\"\u003e\u003c\/line\u003e\n\u003c!-- Grupo ácido \/ sal sódica --\u003e\n\u003cline x1=\"520\" y1=\"200\" x2=\"555\" y2=\"155\"\u003e\u003c\/line\u003e\n\u003cline x1=\"520\" y1=\"200\" x2=\"555\" y2=\"245\"\u003e\u003c\/line\u003e\n\u003c!-- Cloro en núcleo --\u003e\n\u003cline x1=\"120\" y1=\"200\" x2=\"65\" y2=\"200\"\u003e\u003c\/line\u003e\n\u003c\/g\u003e\n\u003c!-- Átomos etiquetados --\u003e\n\u003ccircle cx=\"555\" cy=\"155\" r=\"18\" fill=\"#020a1b\"\u003e\u003c\/circle\u003e\n\u003ctext x=\"555\" y=\"162\" text-anchor=\"middle\" font-size=\"14\" font-weight=\"800\" fill=\"#90D8FF\" font-family=\"Inter,sans-serif\"\u003eO\u003c\/text\u003e\n\u003ccircle cx=\"555\" cy=\"245\" r=\"18\" fill=\"#020a1b\"\u003e\u003c\/circle\u003e\n\u003ctext x=\"555\" y=\"252\" text-anchor=\"middle\" font-size=\"14\" font-weight=\"800\" fill=\"#90D8FF\" font-family=\"Inter,sans-serif\"\u003eONa\u003c\/text\u003e\n\u003ccircle cx=\"65\" cy=\"200\" r=\"18\" fill=\"#020a1b\"\u003e\u003c\/circle\u003e\n\u003ctext x=\"65\" y=\"207\" text-anchor=\"middle\" font-size=\"14\" font-weight=\"800\" fill=\"#2be1ff\" font-family=\"Inter,sans-serif\"\u003eCl\u003c\/text\u003e\n\u003ccircle cx=\"180\" cy=\"155\" r=\"16\" fill=\"#020a1b\"\u003e\u003c\/circle\u003e\n\u003ctext x=\"180\" y=\"162\" text-anchor=\"middle\" font-size=\"13\" font-weight=\"700\" fill=\"#90D8FF\" font-family=\"Inter,sans-serif\"\u003eN\u003c\/text\u003e\n\u003ctext x=\"380\" y=\"145\" text-anchor=\"middle\" font-size=\"12\" font-weight=\"700\" fill=\"#5a8aaa\" font-family=\"Inter,sans-serif\"\u003e(CH₂)₃\u003c\/text\u003e\n\u003ctext x=\"488\" y=\"192\" text-anchor=\"middle\" font-size=\"12\" font-weight=\"700\" fill=\"#5a8aaa\" font-family=\"Inter,sans-serif\"\u003eC=O\u003c\/text\u003e\n\u003c\/svg\u003e\n\u003cdiv class=\"fnx-platform\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-molecule-meta\"\u003e\n\u003cstrong\u003eTianeptina · Sodio\u003c\/strong\u003e\n\u003cspan\u003eC₂₁H₂₄ClN₂NaO₄S · 458.93 g\/mol\u003cbr\u003eCAS 30123-17-2 · PubChem CID 68870\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-science-copy\"\u003e\n\u003cp class=\"kicker\"\u003eLA MOLÉCULA\u003c\/p\u003e\n\u003ch2\u003eTricíclica con cadena tiopropilo.\u003c\/h2\u003e\n\u003cp class=\"fnx-science-lead\"\u003eLa tianeptina es un antidepresivo tricíclico atípico con una cadena lateral de ácido heptanoico sulfonado. Su sal sódica confiere alta solubilidad y biodisponibilidad oral rápida, con un perfil farmacodinámico único entre los moduladores del estado de ánimo.\u003c\/p\u003e\n\u003cdiv class=\"fnx-topics\"\u003e\n\u003carticle class=\"fnx-topic\"\u003e\u003cspan\u003e01\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eNúcleo tricíclico\u003c\/h3\u003e\n\u003cp\u003eEstructura dibenzotiazepínica con el nitrógeno central que media la actividad sobre transportadores de serotonina — inversa a los ISRS clásicos.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-topic\"\u003e\u003cspan\u003e02\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eCadena heptanoica\u003c\/h3\u003e\n\u003cp\u003eCadena lateral de 7 carbonos con grupo ácido terminal — clave para la unión a receptores opioides μ y δ. La sal sódica estabiliza este grupo en solución.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-topic\"\u003e\u003cspan\u003e03\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eSustitución con cloro\u003c\/h3\u003e\n\u003cp\u003eEl cloro en posición 11 del núcleo tricíclico modula la selectividad por el transportador de serotonina y contribuye a la farmacocinética diferenciada respecto a antidepresivos clásicos.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-topic\"\u003e\u003cspan\u003e04\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eSal sódica\u003c\/h3\u003e\n\u003cp\u003eLa contraparte sódica del grupo carboxílico eleva la solubilidad y acelera la absorción oral. Vida media ~2.5h — más corta que el sulfato, relevante en protocolos de dosificación múltiple.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"fnx-benefits\"\u003e\n\u003cdiv class=\"fnx-benefits-intro\"\u003e\n\u003cp class=\"kicker\"\u003eMECANISMO DE ACCIÓN\u003c\/p\u003e\n\u003ch2\u003eCómo actúa la Tianeptina.\u003c\/h2\u003e\n\u003cp\u003eCinco vías documentadas en la literatura farmacológica. Sin afirmaciones clínicas — solo farmacología comparada.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-benefits-grid\"\u003e\n\u003carticle class=\"fnx-benefit\"\u003e\u003cspan class=\"fnx-benefit-num\"\u003e01\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003ePotenciación de recaptación 5-HT\u003c\/h3\u003e\n\u003cp\u003eAumenta la recaptación de serotonina en neuronas corticales y del hipocampo — opuesto a ISRS. Normaliza la hiperactividad serotoninérgica en modelos de estrés crónico.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-benefit\"\u003e\u003cspan class=\"fnx-benefit-num\"\u003e02\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eAgonismo μ \/ δ-opioide\u003c\/h3\u003e\n\u003cp\u003eActividad agonista documentada sobre receptores opioides a dosis supraterapéuticas. Base del potencial de dependencia y objeto central de investigación comparativa.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-benefit\"\u003e\u003cspan class=\"fnx-benefit-num\"\u003e03\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eNeuroplasticidad hipocampal\u003c\/h3\u003e\n\u003cp\u003ePreviene la atrofia dendrítica inducida por estrés. Potencia la neurogénesis en el giro dentado — efecto independiente de la vía serotoninérgica.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-benefit\"\u003e\u003cspan class=\"fnx-benefit-num\"\u003e04\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eModulación AMPA \/ BDNF\u003c\/h3\u003e\n\u003cp\u003eRegula la expresión de receptores AMPA y la síntesis de BDNF en corteza prefrontal — mecanismo relevante para investigación sobre resiliencia al estrés.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-benefit\"\u003e\u003cspan class=\"fnx-benefit-num\"\u003e05\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eEje HPA y cortisol\u003c\/h3\u003e\n\u003cp\u003eNormaliza la respuesta del eje hipotálamo-hipófisis-adrenal bajo condiciones de estrés crónico. Reduce la hipercortisolemia en modelos animales de depresión.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"fnx-audience\"\u003e\n\u003cheader\u003e\n\u003cp class=\"kicker\"\u003eIDENTIDAD QUÍMICA\u003c\/p\u003e\n\u003ch2\u003ePerfil molecular.\u003c\/h2\u003e\n\u003c\/header\u003e\n\u003cdiv class=\"fnx-audience-grid\"\u003e\n\u003carticle class=\"fnx-audience-item\"\u003e\u003ch3\u003eFórmula · C₂₁H₂₄ClN₂NaO₄S\u003c\/h3\u003e\n\u003cp\u003eTricíclico dibenzotiazepínico con cadena heptanoica sulfonada, sal sódica. Masa molecular 458.93 g\/mol. Alta solubilidad acuosa respecto al sulfato.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-audience-item\"\u003e\u003ch3\u003eCAS 30123-17-2 · PubChem CID 68870\u003c\/h3\u003e\n\u003cp\u003eIdentificadores verificables en PubChem y bases de datos de referencia farmacológica internacional. Nombre IUPAC: Sodio 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate S,S-dioxide.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-audience-item\"\u003e\u003ch3\u003ePresentación · 12.5 mg · 90 cápsulas\u003c\/h3\u003e\n\u003cp\u003e1,125 mg totales. Cápsulas de gelatina. Dosificación estándar en investigación: 12.5 mg 2–3 veces\/día. Almacenar a 15–25 °C, protegido de humedad y luz directa.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-audience-item\"\u003e\u003ch3\u003eClasificación RUO\u003c\/h3\u003e\n\u003cp\u003eNo aprobado por la FDA para uso en humanos. Restricciones activas en múltiples estados de EE.UU. (Alabama, Arkansas, Georgia, Indiana, Michigan, Minnesota, Ohio, Tennessee, Virginia). Solo para investigación científica.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"fnx-questions\"\u003e\n\u003cheader\u003e\n\u003cp class=\"kicker\"\u003ePREGUNTAS CLAVE\u003c\/p\u003e\n\u003ch2\u003eResuelve tus dudas.\u003c\/h2\u003e\n\u003c\/header\u003e\n\u003cdiv\u003e\n\u003carticle class=\"fnx-question\"\u003e\u003ch3\u003e¿Por qué sal sódica y no sulfato?\u003c\/h3\u003e\n\u003cp\u003eLa sal sódica presenta mayor solubilidad acuosa, absorción más rápida (~30 min) y vida media más corta (~2.5h) frente al sulfato (~4–6h). Son formas complementarias para protocolos de investigación con distintos objetivos farmacocinéticos.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-question\"\u003e\u003ch3\u003e¿Cuál es el rango de dosis en investigación?\u003c\/h3\u003e\n\u003cp\u003eLa literatura clínica europea documenta 12.5 mg 2–3 veces\/día (25–37.5 mg\/día total) con las comidas principales. La forma sódica requiere mayor frecuencia de administración que el sulfato por su vida media más corta.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-question\"\u003e\u003ch3\u003e¿Tiene potencial de dependencia?\u003c\/h3\u003e\n\u003cp\u003eSí — reportes clínicos y la actividad sobre receptores opioides documentan potencial de dependencia y síndrome de abstinencia con uso crónico. Relevante como variable en protocolos de investigación sobre neuroadaptación.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-question\"\u003e\u003ch3\u003e¿Por qué está disponible solo como RUO?\u003c\/h3\u003e\n\u003cp\u003eLa FDA nunca aprobó la tianeptina para uso médico en EE.UU. Tras reportes de abuso y eventos adversos graves, múltiples estados la clasificaron como sustancia controlada. Disponible únicamente como material de referencia para investigación científica.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\u003csection class=\"fnx-close\"\u003e\n\u003cdiv class=\"fnx-close-copy\"\u003e\n\u003cp class=\"kicker\"\u003eRESEARCH USE ONLY · NOOTROPICS DEPOT\u003c\/p\u003e\n\u003ch2\u003eTianeptina Sodio · 12.5 mg · 90 cápsulas · 1,125 mg totales.\u003c\/h2\u003e\n\u003cp\u003eModulador serotoninérgico atípico de alta pureza. Material de referencia certificado para investigación sobre neuroplasticidad y farmacología opioide. CAS 30123-17-2 · Solo para investigación científica.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-actions\"\u003e\n\u003ca class=\"fnx-btn fnx-btn-primary\" href=\"#AddToCart\"\u003eAgregar al carrito\u003c\/a\u003e\n\u003ca class=\"fnx-btn fnx-btn-secondary\" href=\"https:\/\/api.whatsapp.com\/send\/?phone=525542463084\u0026amp;text=Hola%2C%20tengo%20una%20duda%20sobre%20Tianeptine%20Sodium%20Nootropics%20Depot\u0026amp;type=phone_number\u0026amp;app_absent=0\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eConsultar por WhatsApp\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv style=\"margin-top:24px;padding:14px 32px;background:rgba(2,8,22,.95);border:1px solid rgba(0,150,255,.1);border-radius:14px\"\u003e\u003cp style=\"margin:0;color:#1a3a5a;font-size:11.5px;line-height:1.7;text-align:center\"\u003eEsta sustancia es para investigación y no para consumo humano o veterinario. · CAS 30123-17-2 · Nootropics Depot · Nootrópicos México.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Nootrópicos México ","offers":[{"title":"Default Title","offer_id":43755780505667,"sku":null,"price":1299.0,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1156\/1718\/files\/E642FD15-63DB-404F-BEEB-9372FD451393_ba6fe69b-6e76-47fb-a5a7-32ccbd52167b.png?v=1788479475","url":"https:\/\/nootropicosmexico.com\/products\/tianeptine-sodium-125mg-90-capsulas-nootropics-depot","provider":"Nootrópicos México ","version":"1.0","type":"link"}